Analystreport

Collegium Pharmaceutical Inc (NASDAQ: COLL) had its price target raised by analysts at HC Wainwright from $25.00 to $29.00. They now have an "in-line" rating on the stock.

Collegium Pharmaceutical, Inc.  (COLL) 
Last collegium pharmaceutical, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.collegiumpharma.com